MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'aids drugs'. Sat, 03 Sep 2011 02:50:14 +0100 http://www.medworm.com/index.php?rid=5139683&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FIyG05aaQWBI%2F Viagra Protection: A federal judge ruled yesterday that a Pfizer patent on the erectile-dysfunction treatment Viagra is valid and enforceable, protecting the blockbuster drug against generic competition until 2019, the WSJ reports. Teva Pharmaceutical had proposed a generic version of the drug, arguing that certain claims of that 2019 Pfizer patent were invalid, the paper says. Cheap Screening: Hospitals are advertising inexpensive low-dose CT scans for current and former smokers on the heels of a government study that found such lung-cancer screening can save lives in a certain group of people, Kaiser Health News reports. But the study didn’t fully answer questions about who might benefit from the screening and how they should be screened, and the tests produce a lot of false positi... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=5139683 Tue, 16 Aug 2011 12:43:51 +0100 5139683 http://www.medworm.com/index.php?rid=5096157&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FBHxwkhyvIwY%2F Medicare a Likely Target: The deal reached to increase the debt ceiling will mean a bipartisan group of legislators will be seeking an additional $1.5 trillion in cuts later this fall, and health-care spending, including on Medicare, is likely to be in the crosshairs, the WSJ reports. Some form of means-testing and raising the age of Medicare eligibility will probably be on the table, the paper says. If Congress fails to approve sufficient cuts, automatic spending cuts, namely lower payments to providers, will go into effect automatically. Not Effective: Research published in the Journal of the American Medical Association suggests that Risperdal — and, possibly, similar antipsychotic drugs — doesn’t ease post-traumatic stress disorder symptoms in veterans, the New York T... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=5096157 Wed, 03 Aug 2011 10:20:30 +0100 5096157 http://www.medworm.com/index.php?rid=5086137&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FY2g0k-H0Yys%2F Paying Up: Getting a drug approved is only the first step for pharma companies as insurance companies and governments crack down on spending by focusing on the value that a new medication will bring, the WSJ reports. AstraZeneca, for example, will be negotiating with U.S. insurers over the next year, hoping to convince them that the new anti-clotting drug Brilinta is worth the $7.24 per day it plans to charge. That’s a 20% premium over the current gold-standard treatment, Plavix, which will lose patent protection next year, the paper says. “Lab On a Chip”: A report published online by Nature Medicine shows that a small device that can be used in the field accurately detected both HIV and syphilis in a group of Rwandan people, the Washington Post reports. The so-called lab... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=5086137 Mon, 01 Aug 2011 12:46:43 +0100 5086137 http://www.medworm.com/index.php?rid=5050510&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FXBJnKrBGmtg%2F In Short Supply: Johnson & Johnson is experiencing a shortage of its cancer drug Doxil due to production delays at a contract manufacturer, the WSJ reports. The company is advising doctors not to start new patients on the drug and to consult national treatment guidelines for alternatives. A recent survey found 99.5% of hospitals have experienced a shortage of at least one drug in the past six months. Uh Oh: Researchers at Boston University retracted a study published online last year in Science that claimed to pinpoint a set of genetic markers linked to living past 100, the Boston Globe reports. Science said technical errors and inadequate quality-control procedures, not misconduct, sparked the retraction, and that once re-crunched, the data didn’t meet “the journal’s... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=5050510 Fri, 22 Jul 2011 12:38:25 +0100 5050510 http://www.medworm.com/index.php?rid=4872053&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2Fo0F-VmVKWyc%2F Study’s Reverberations?: Abbott’s Niaspan setback has implications for Merck and Roche, which are also trying to develop drugs that raise good cholesterol and can be added to statins, which lower the bad kind, the WSJ reports. Merck, for example, is conducting a 25,000-person trial to test its own niacin-based drug tredaptive. A Merck exec tells the WSJ it’s way too early to judge niacin’s potential by these latest results alone. Unifying Records: The Defense Department and Department of Veterans Affairs plan to jointly develop a computerized system to keep military members’ health records in one place throughout their career and retirement, the New York Times reports. Officials say an interoperable system will reduce lost paperwork, speed the delivery of care... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4872053 Fri, 27 May 2011 12:44:45 +0100 4872053 http://www.medworm.com/index.php?rid=4820802&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FKMhuxajpNik%2F As we noted a few years ago, the same antiretroviral drugs used to treat HIV infection and AIDS are also being eyed as a way to prevent the spread of the disease. That notion is shored up by new research showing that treating HIV-infected people with the drugs dramatically reduces the odds they’ll transmit the virus to a sexual partner, at least if that partner is of the opposite gender. (Couples participating in the study were almost all heterosexual, so researchers warn the same results may not hold for homosexual couples.) As the WSJ reports, researchers randomly divided 1,763 couples — one person was infected with HIV; the other wasn’t — into two groups. Infected partners in one group immediately started an antiretroviral drug regimen. Those in the other started... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4820802 Fri, 13 May 2011 14:22:30 +0100 4820802 http://www.medworm.com/index.php?rid=4696606&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FzhNMAxStySE%2F Endo Buys: Endo Pharmaceutical Holdings will pay about $2.6 billion in cash for American Medical Systems, which makes minimally invasive products to treat men’s and women’s pelvic health conditions, the WSJ reports. The purchase price includes the assumption of $312 million in debt. Time Out on Vaccine: Merck and Intercell AG said the independent data monitoring committee for a trial studying the companies’ experimental vaccine against the Staphylococcus aureus bacteria recommended study enrollment be halted, Bloomberg News reports. The committee needs to crunch the numbers to analyze the vaccine’s risk-benefit ratio, BN says; Intercell’s CEO says the development doesn’t mean the vaccine has failed. Calling for Change: The CDC is preparing to recommend t... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4696606 Mon, 11 Apr 2011 12:34:32 +0100 4696606 http://www.medworm.com/index.php?rid=4155225&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FOtZ-Dh23Zms%2F Also: first drug approved to treat fat deposits associated with anti-HIV therapy; J&J talks to the government about Risperdal; ADHD incidence is up. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4155225 Thu, 11 Nov 2010 13:54:21 +0100 4155225 http://www.medworm.com/index.php?rid=3636019&cid=t_142749_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fh0HyKefJllM%2F In its latest effort to lower the cost of HIV drugs, the AIDS Healthcare Foundation is now mailing postcards directly to the homes of Bristol-Myers Squibb employees in the Princeton, NJ, area - where the drugmaker has its main laboratory complex - that feature a picture of ceo Lamberto Andreotti stuffing a $20 bill into his pocket as many more bills fall out of the sky behind him (read the text here). The average wholesale price for Reyataz is $13,046 a year, according to AHF, which adds that other “commonly precribed” first-line AIDS drugs are priced $3,000 to $5,400 less. AHF also accuses the drugmaker of raising the price of Reyataz several times - since it was approved in 2003, the price has increased more than 25 percent. The drug, by the way, must be taken with at least t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3636019 Mon, 07 Jun 2010 13:58:38 +0100 3636019 http://www.medworm.com/index.php?rid=3378444&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2Fh8NM3LdOMlU%2F Getting one drug through the FDA approval process is hard enough but getting the go-ahead for multiple medicines at once so they can be used together in so-called drug cocktails can be Herculean. Now the agency is devising guidelines to speed up testing and approval of multidrug regimens for some of the world’s most deadly diseases, such as AIDS, tuberculosis and cancer, the WSJ reports this morning. Such a policy would be a first for the FDA, a spokesman says. Two pharmaceutical consortia want to use the new approach, the article says. One is a group of 10 drug companies and several nonprofit organizations convened by the Bill and Melinda Gates Foundation to develop medicines to fight tuberculosis. The other is an effort by Merck and AstraZeneca, which are jointly testing two antica... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3378444 Thu, 18 Mar 2010 12:28:41 +0100 3378444 http://www.medworm.com/index.php?rid=2473219&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FHDY4qLU1hA8%2F Drug makers have touted the importance of expanding in emerging markets like Russia, China and India to drive growth outside the slowing U.S. market. But one challenge is figuring out how to price drugs in those markets. A continuing dispute between GlaxoSmithKline and the Russian government over the pricing of HIV medicines illustrates the conundrum for companies of maintaining an acceptable profit margin vs. gaining market share, according to the WSJ. Russia wants GSK to lower the price of its anti-retroviral medication Combivir by 15%. GSK refuses, saying that such a price wouldn’t be able to support a “viable business model,” according to Glaxo’s general manager in Russia, Fabio Landazabal, reports the WSJ. “Pricing of this level is clearly not sustainable... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=2473219 Fri, 12 Jun 2009 12:41:48 +0100 2473219 http://www.medworm.com/index.php?rid=2138316&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FyAaSV8gPuJg%2F Associated Press Martin Delaney in 1991 Martin Delaney, an activist who launched what he called “medically supervised guerrilla trials” of AIDS drugs in the early 1980s, died Friday of liver cancer. He was 63. Delaney never had HIV himself. In 1978, he was diagnosed with hepatitis B and told that he had only months to live, the Los Angeles Times says in its obit. But he was able to enroll in a clinical trial of interferon, which put him into remission. When his friends started dying of AIDS a few years later, Delaney launched a nonprofit called Project Inform that pushed for clinical trials of the largely untested drugs many AIDS patients were taking. That kind of activism ultimately transformed the relationship between dying patients and the drug research establishment, openi... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=2138316 Wed, 28 Jan 2009 10:46:37 +0100 2138316 http://www.medworm.com/index.php?rid=1631816&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F336066282%2F Ranbaxy shares fell again today in London on news that the U.S. government is investigating the Indian generics giant. The feds are looking into whether the company manufactured substandard drugs, including those given to HIV patients in Africa as part of a U.S.-funded program, the WSJ reports. U.S. investigators are looking into possible fraud, false claims and fabrication of documents, according to court documents. In a court filing, the company said that “except for issues that have been fully aired with the government, Ranbaxy knows of no evidence to support these allegations.” Ranbaxy sells scads of drugs in the U.S. including simvastatin, a generic version of Merck’s cholesterol drug Zocor. The company is in the midst of selling a majority stake to the Japanese dr... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1631816 Thu, 17 Jul 2008 13:16:14 +0100 1631816 http://www.medworm.com/index.php?rid=1242491&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F237766750%2F GlaxoSmithKline, one of the world’s biggest makers of HIV drugs, said it is cutting prices of its HIV drugs in the world’s poorest countries, marking its fifth rollback since 1997. Prices of 14 Glaxo HIV medicines will fall an average of 21%, the company said. Glaxo sells its HIV drugs at cost in 64 of the world’s poorest countries. The company said improvements in manufacturing and the availability of cheaper raw ingredients have made the latest round of price cuts possible. The deepest cut will be on Ziagen, whose liquid form the World Health Organization recommends for use in children. Ziagen’s price will drop by 40% to $15.08 per pack or 50 cents a day. The most costly drug, called Lexiva, will have a new price of $3.35 a day, after a 20% reduction, Glaxo said. Glaxo... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1242491 Tue, 19 Feb 2008 22:07:57 +0100 1242491 http://www.medworm.com/index.php?rid=1222482&cid=t_142749_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F233151763%2F After last year’s disappointing news about the failure of Merck’s once-promising HIV vaccine, there’s progress on a new front. This past weekend brought word that government scientists discovered another method HIV uses in its attack, reports this morning’s New York Times. The finding could open the door for new approaches to stop AIDS, the paper reports. A team headed by veteran HIV researcher Anthony Fauci (pictured), director of the National Institute of Allergy and Infectious Diseases, found a human receptor — a molecule called integrin alpha-4 beta-7 — that helps guide the AIDS virus to the gut after it enters the body. The gut becomes a key place for the virus to replicate. When scientists determine the role that human molecules play in making a ho... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1222482 Mon, 11 Feb 2008 21:28:32 +0100 1222482 http://www.medworm.com/index.php?rid=822306&cid=t_142749_87_f&fid=34866&url=http%3A%2F%2Fwww.thecardioblog.com%2F2007%2F08%2F25%2Fplavix-and-thailand-why-you-should-care%2F Filed under: Drugs, Daily newsThe Thai government says the heart drug Plavix is way overpriced. And it's going to do something about it: it will begin importing generic versions of Plavix from India. The first batch of two million pills will arrive soon, says the chairman of Thailand's Government Pharmaceutical Organisation. The imported version of Plavix, a blood-thinner, will cost only the equivalent of three US cents per pill. Compare this with the current cost for Thai heart patients: two US dollars per pill!In order to do all this, the Thai government approved a temporary suspension of patent protections for expensive medications. Needless to say, this has seriously ticked off the big pharmaceutical companies! (Plavix, by the way, is sold by Sanofi-Aventis and Bristol Myers-Squibb.) H... The Cardio Blog blogs http://www.medworm.com/rss/comments.php?id=822306 Sat, 25 Aug 2007 04:00:00 +0100 822306